Abstract:692 Background: Urinary extracellular vesicles (uEVs) secreted directly from BCa are considered a promising tool for diagnosing BCa, as they contain cancer-specific molecules. Among them, proteins in uEVs have attracted considerable attention, and several membrane EV proteins have been reported as urinary markers for BCa. However, few studies have focused on non-membranous (cytoplasmic) EV proteins. This study aimed to explore and validate a uEV-based diagnostic marker for BCa, focusing on cytoplasmic EV proteins. In addition, the functions of the identified protein were assessed. Methods: uEVs were isolated by ultracentrifugation with a sucrose cushion. Shotgun proteomics (TMT-labeled LC-MS/MS) was performed on uEVs from seven patients with BCa and four healthy individuals. Diagnostic marker candidates were selected from the identified cytoplasmic EV proteins and validated with targeted proteomics (SRM/MRM) of uEVs from 49 patients with BCa and 48 individuals without BCa, including patients with hematuria. The functional analysis of the identified EV protein was conducted in vitro. Results: Shotgun proteomics identified 1960 proteins, of which 17 cytoplasmic EV proteins were significantly elevated in the uEVs from patients with BCa (Fold change >1.5, p-value < 0.05). Of these, all ten measurable EV proteins were confirmed to be significantly elevated in urine from patients with BCa, of which EV-EIF2S1 showed the best diagnostic performance (ROCAUC: 0.83, sensitivity: 80%, specificity: 77%) in the validation cohort. Additionally, EV-EIF2S1 distinguished patients with BCa from non-BCa hematuria patients in a suitable manner (ROCAUC: 0.92, sensitivity: 82%, specificity: 83%). In the functional analysis of EIF2S1 in BCa cell lines T24 and 5637, the knockdown of EIF2S1 markedly inhibited cell proliferation. Cell cycle studies showed that the knockdown of EIF2S1 resulted in cell cycle arrest and induction of apoptosis. Therefore, EIF2S1 was considered an essential protein for the growth and survival of BCa cells. Conclusions: We identified EIF2S1 in uEVs as a novel diagnostic marker for BCa, enabling accurate and non-invasive diagnosis for BCa in a hematuria setting.

EIF2S1 as a novel diagnostic marker for bladder cancer in urinary extracellular vesicles.

Proteomic analysis of urinary and tissue‐exudative extracellular vesicles to discover novel bladder cancer biomarkers

Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients

Cross-sectional and longitudinal analyses of urinary extracellular vesicle mRNA markers in urothelial bladder cancer patients

Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification

An Integrated Double-Filtration Microfluidic Device for Detection of Extracellular Vesicles from Urine for Bladder Cancer Diagnosis.

Profiling of urinary extracellular vesicle protein signatures from patients with cribriform and intraductal prostate carcinoma in a cross-sectional study

Tumour tissue‐derived small extracellular vesicles reflect molecular subtypes of bladder cancer

Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles

tRNA-Derived Fragments as Biomarkers in Bladder Cancer

Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances

Extracellular vesicle-transferred long noncoding RNAs in bladder cancer

Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis

Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging

An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer

Identification and validation of the surface proteins FIBG, PDGF-β, and TGF-β on serum extracellular vesicles for non-invasive detection of colorectal cancer: experimental study

High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate Cancer Diagnosis

Blood Extracellular Vesicles Beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients

UPCARE: Urinary Extracellular Vesicles-Derived Prostate Cancer Assessment for Risk Evaluation

Combination of Urine Exosomal mRNAs and lncRNAs as Novel Diagnostic Biomarkers for Bladder Cancer

Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy